Research programme: anti-Ebola antibody - XBiotech

Drug Profile

Research programme: anti-Ebola antibody - XBiotech

Alternative Names: True Human™ Ebola antibody therapeutic

Latest Information Update: 27 Nov 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator XBiotech
  • Class Antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Ebola virus infections

Most Recent Events

  • 09 Nov 2015 Preclinical trials in Ebola virus infections in USA (Parenteral)
  • 19 Oct 2015 XBiotech receives patent allowance for its True Human™ antibody technology in USA
  • 26 May 2015 Early research in Ebola virus infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top